Skip to main content
Christopher O'Connor, MD, Cardiology, Falls Church, VA, Inova Fairfax Medical Campus

ChristopherMO'ConnorMDMACC, FESC, FHFSA, FHFA

Cardiology • Falls Church, VA

President - Inova Heart & Vascular Institute | Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. O'Connor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. O'Connor's full profile

Already have an account?

  • Office

    3300 Gallows Rd
    Inova Heart & Vascular Institute
    Falls Church, VA 22042
    Phone+1 571-472-2900
    Fax+1 703-776-3515
  • Is this information wrong?

Summary

  • Dr. O’Connor came to IHVI in 2015, having previously served as director of the Duke Heart Center and Chief of the Divisions of Cardiology and Clinical Pharmacology at Duke University Medical Center. He is highly regarded internationally for leadership in clinical trials addressing therapeutics for the treatment of acute and chronic heart failure. He has obtained millions of dollars in private research grants and secured multiple R01 and U01 grants from the National Heart, Lung and Blood Institute as principal and co-principal investigator.

    Dr. O’Connor is Professor of Medicine, Duke University and Editor in Chief Emeritus of JACC: Heart Failure. He serves on the editorial boards for various top-tier medical and cardiovascular journals and has authored more than 900 publications, 3 textbooks and 15 textbook chapters. He has consistently been an invited speaker and moderator at the annual scientific meetings of national and international societies, has served in leadership roles in major professional societies, is a Past President of the Heart Failure Society of America and is the 2021 recipient of the American College of Cardiology’s Distinguished Clinical Scientist Award.
    During his tenure at IHVI, Dr. O’Connor has applied the scientific rigor of a clinical investigator to promote a culture of excellence in research and bring about outstanding clinical outcomes.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1983 - 1986
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1983
  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1987 - 2024
  • VA State Medical License
    VA State Medical License 2015 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Distinguished Scientist Award American College of Cardiology, 2021
  • Master of the American College of Cardiology (MACC) 2018
  • Honor Award and Gold Key Recipient University of Maryland, 2018
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Best of JACC: Heart Failure 2018 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Defining the Appropriate Role for Implantable Mechanical Devices to Treat Heart Failure: Where are We Now and Where are We Going? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Interventional Heart Failure 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Join now to see all

Press Mentions

  • Yale New Haven Health's Planned 3-Hospital Acquisition 'Critical' to Growth, CEO Says
    Yale New Haven Health's Planned 3-Hospital Acquisition 'Critical' to Growth, CEO SaysJanuary 23rd, 2023
  • Omecamtiv Mecarbil Not Ready for Prime Time, FDA Advisors Say
    Omecamtiv Mecarbil Not Ready for Prime Time, FDA Advisors SayDecember 13th, 2022
  • FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Control
    FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus ControlNovember 17th, 2022

Professional Memberships

  • American College of Cardiology - ACC
    Member
  • FDA Cardiovascular and Renal Advisory Committee
    Member
  • HFSA Research Committee
    Chair
  • Heart Failure Collaboratory
    Principal Investigator
  • Heart Failure Society of America (FHFSA)
    Fellow
  • ESC-Heart Failure Association (FHFA)
    Fellow
  • European Society of Cardiology
    Fellow

Hospital Affiliations

Dr. Christopher O'Connor, Dr. Christopher O'Connor, MD, Dr. C O'Connor, Dr. Christopher M O'Connor